Quick Read JPMorgan raised its Colgate-Palmolive (CL) stock  price target to $96 from $95, citing emerging markets exposure ...

Strong overseas appetite for everyday consumer goods — including oral and personal care products — helped Colgate-Palmolive ...

Colgate-Palmolive Company (NYSE:CL) reported first-quarter results that exceeded analyst expectations, with adjusted earnings per share of $0.97 compared to the consensus estimate of $0.94 and revenue ...

Perspective is essential when investing. For example, market participants who are scoping out consumer packaged goods stocks as potential rebound opportunities for 2026 may be on to something, because ...

Valued at a market cap of $68.5 billion, Colgate-Palmolive Company (CL) is a leading consumer products company based in New ...

Is CL a good stock to buy? We came across a bullish thesis on Colgate-Palmolive Company on Investing Lawyer’s Substack. In this article, we will summarize the bulls’ thesis on CL.

Colgate-Palmolive Company CL has experienced steady growth over the past year, fueled by its strong leadership in the oral care market and science-driven innovations that have bolstered its core and ...

We think that Colgate-Palmolive stock (NYSE: CL) is currently a better pick over its industry peer – Kimberly-Clark stock (NYSE: KMB). CL stock trades at 3.5x trailing revenues, versus 2.1x for KMB.

With consumer staples stocks out of favor, Colgate-Palmolive's share price slumped in 2025. The company has accelerated its product development pace. Colgate-Palmolive has met or exceeded its organic ...